After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...

Ashley Park discussed her childhood cancer journey at SXSW in Austin March 14.

New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...

A local mother is doing what she can to support her son as he battles leukemia. Thankfully, she is getting support from her ...

From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...

For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, according to a study recently published in Bone Marrow Transplantation.

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

Key Takeaways A highly sensitive DNA test can detect hidden leukemia cells that predict if a patient’s cancer is likely to ...

Red nodules on the lower legs can sometimes be an early sign of acute myeloid leukemia (AML). AML is a cancer of the blood and bone marrow that is more common in adults over age 55. While AML is a ...